Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Side-by-side comparison Factor Receptor targets Semaglutide GLP-1 only Tirzepatide GLP-1 + GIP Retatrutide GLP-1 + GIP + glucagon Liraglutide GLP-1 only Factor Half-life Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Liraglutide ~13 hours Factor Dosing frequency Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Liraglutide Once daily Factor Max studied dose Semaglutide 2.4 mg/week (SubQ)
doi: 10.1097/FPC.0b013e3283559b22 48 GrahamG
Research peptides are sold for laboratory use and have not received regulatory approval for human treatment
He stressed anyone considering them should first consult a health-care professional
This adaptive thermogenesis is a normal physiological response but can be uncomfortable for some individuals
Obesity, 29 (7), 1102-1113
US$ 29.68
US$ 26.27
US$ 21.78
